Fig. 5
From: Systemic PCSK9 elevation characterises autoimmune liver disease across sexes
PCSK9 for prognosis of decompensation. (a) PCSK9 levels of patients with primary sclerosing cholangitis without and with decompensation. (b) PCSK9 levels of patients with primary biliary cholangitis without and with decompensation.
